Polypharmacology in Alzheimer’s Disease: Integrating AI, Network Pharmacology, and Experimental Validation

作者
Saurabh Kumar
标识
DOI:10.64252/v0k8cn36
摘要

Alzheimer’s disease (AD), the leading cause of dementia, is a progressive neurodegenerative disorder characterized by amyloid-β plaques, tau tangles, oxidative stress, mitochondrial dysfunction, and neuroinflammation. Current monotherapies, designed using a “one drug-one target” approach, provide only symptomatic relief without altering disease progression. Polypharmacology, through the development of multi-target-directed ligands (MTDLs), offers a promising therapeutic strategy that simultaneously modulates multiple interconnected pathways in AD pathology. This review highlights the integration of computational and experimental approaches in the discovery of MTDLs. In silico tools, such as molecular docking, pharmacophore modeling, QSAR, network pharmacology, and artificial intelligence, facilitate the prediction and design of polypharmacological agents. In vitro, in vivo, and omics-based studies have validated their therapeutic relevance. Hybrid molecules, including ladostigil, M-30, ASS234, donecopride, and chalcone–rivastigmine hybrids, demonstrate multi-faceted neuroprotection by targeting cholinergic dysfunction, amyloid aggregation, oxidative stress, and neuroinflammation. Despite challenges such as off-target effects and translational limitations, advances in AI-driven platforms, systems biology, and human-relevant models, such as brain organoids, are expected to accelerate the development of disease-modifying therapies. Polypharmacology represents a paradigm shift in AD treatment, moving beyond symptomatic relief towards mechanism-informed interventions with the potential to slow or halt disease progression.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
尧尧发布了新的文献求助10
1秒前
优秀绝悟完成签到,获得积分10
2秒前
2秒前
寒冷树叶完成签到 ,获得积分10
2秒前
啦啦啦啦啦啦啦完成签到,获得积分10
3秒前
一颗葡萄完成签到 ,获得积分10
3秒前
gly完成签到,获得积分10
3秒前
4秒前
4秒前
5秒前
xili完成签到,获得积分10
5秒前
SiO2完成签到 ,获得积分0
7秒前
CarryLJR的应助被ad采纳,获得10
7秒前
8秒前
RosecLuo完成签到 ,获得积分10
8秒前
maT发布了新的文献求助10
8秒前
帅气糖豆完成签到 ,获得积分10
9秒前
9秒前
lou发布了新的文献求助10
9秒前
10秒前
10秒前
饿了么完成签到,获得积分10
10秒前
11秒前
科研通AI6.4的应助被gbh采纳,获得10
11秒前
majiaqi发布了新的文献求助10
12秒前
12秒前
12秒前
12秒前
CarryLJR的应助被tuffer采纳,获得10
13秒前
13秒前
自由大叔发布了新的文献求助10
14秒前
沈自耕发布了新的文献求助10
14秒前
babyapple完成签到 ,获得积分10
15秒前
15秒前
姚佳麒完成签到,获得积分10
15秒前
15秒前
leclerc发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179017
求助须知:如何正确求助?哪些是违规求助? 9569679
关于积分的说明 21805795
捐赠科研通 7774108
什么是DOI,文献DOI怎么找? 3432979
关于科研通互助平台的介绍 2556897
邀请新用户注册赠送积分活动 2478640